UOC
ERAS icon

UBS O'Connor’s Erasca ERAS Stock Holding History

UBS O'Connor’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,627
Closed -$104K – 409
2025
Q1 		$104K Sell
75,627
-153,973
-67% -$264K ﹤0.01% 265
2024
Q4 		$576K Buy
229,600
+159,600
+228% +$438K 0.01% 269
2024
Q3 		$191K Buy
+70,000
New +$197K ﹤0.01% 390

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

UBS O'Connor's ERAS Position: Q2 2025 in Review

UBS O'Connor sold out of Erasca (ERAS) in Q2 2025, closing a stake of 75,627 shares — an estimated $104K sold.

UBS O'Connor first reported a position in ERAS in Q3 2024 and held it in 3 quarters. The position peaked at $576K in Q4 2024. 142 funds tracked by Wall St. Rank hold ERAS as of Q2 2025.

  • UBS O'Connor reported no remaining Erasca position as of Q2 2025 after selling out during the quarter.
  • UBS O'Connor sold 75,627 Erasca shares in Q2 2025, an estimated $104K.
  • UBS O'Connor first reported a position in Erasca in Q3 2024 and held it in 3 quarters.
  • UBS O'Connor's Erasca position peaked at $576K in Q4 2024.
  • 142 funds tracked by Wall St. Rank held Erasca as of Q2 2025.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.